Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Camrelizumab”

370 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 370 results

Large-scale testing (Phase 3)UnknownNCT04768075
What this trial is testing

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Guangdong Association of Clinical Trials 200
Testing effectiveness (Phase 2)UnknownNCT04826406
What this trial is testing

Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint Inhibitors
Hunan Cancer Hospital 40
Large-scale testing (Phase 3)UnknownNCT05042375
What this trial is testing

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 450
Not applicableLooking for participantsNCT06061276
What this trial is testing

BTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Who this might be right for
Liver DiseasesHepatocellular CarcinomaImmunotherapy+2 more
Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT04367025
What this trial is testing

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 70
Testing effectiveness (Phase 2)UnknownNCT05171309
What this trial is testing

Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 35
Large-scale testing (Phase 3)UnknownNCT04203485
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
PD-L1 Positive Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 762
Not applicableUnknownNCT04741490
What this trial is testing

Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery

Who this might be right for
Esophageal Squamous Cell Carcinomas
Fuzhou General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04694183
What this trial is testing

The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
Quan Wang 37
Testing effectiveness (Phase 2)Ended earlyNCT05208177
What this trial is testing

SHR-1802 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Jiangsu HengRui Medicine Co., Ltd. 25
Testing effectiveness (Phase 2)Looking for participantsNCT06811844
What this trial is testing

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

Who this might be right for
Nasopharyngeal NeoplasmsPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University 208
Testing effectiveness (Phase 2)UnknownNCT04828395
What this trial is testing

Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 65
Testing effectiveness (Phase 2)UnknownNCT04861467
What this trial is testing

Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCC
Chinese Academy of Medical Sciences 155
Not applicableUnknownNCT04559607
What this trial is testing

TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 188
Early research (Phase 1)Ended earlyNCT03871855
What this trial is testing

SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid Tumors

Who this might be right for
Advanced Solid Tumor
Jiangsu HengRui Medicine Co., Ltd. 8
Large-scale testing (Phase 3)Looking for participantsNCT04453826
What this trial is testing

Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CancerChemotherapyRadiotherapy+1 more
Sun Yat-sen University 388
Testing effectiveness (Phase 2)UnknownNCT05669807
What this trial is testing

Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

Who this might be right for
Second Line Treatment of Gastric Cancer
Zhejiang Cancer Hospital 184
Testing effectiveness (Phase 2)Looking for participantsNCT05097209
What this trial is testing

Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 200
Testing effectiveness (Phase 2)UnknownNCT04683198
What this trial is testing

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 69
Large-scale testing (Phase 3)Ended earlyNCT04985136
What this trial is testing

Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 1
Load More Results